v3.26.1
Segments of Operations - Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss [Line Items]          
Revenues $ 4,156 $ 3,040 $ 8,467 $ 5,855  
Cost of revenues 7,135 6,280 14,034 12,144  
Cost of revenues – Impairment of intangible assets 40,695   40,695    
Segment gross profit (loss) (43,674) (3,240) (46,262) (6,289)  
Research and development, net 4,707 4,834 9,505 9,812  
Sales and marketing 1,900 1,239 4,064 2,178  
General and administrative 5,444 5,127 10,684 10,265  
Other segment items (248) [1] 51 [2] (480) [3] 37 [2]  
Segment operating loss (55,477) (14,491) (70,035) (28,581)  
Financial income (expense), net (61) (149) 308 616  
Loss before taxes on income (55,538) (14,640) (69,727) (27,965)  
Depreciation expense 314 299 629 586  
Amortization expense 2,505 2,653 5,009 5,306  
Stock based compensation 869 1,111 1,710 2,277  
Total Assets 91,185 184,232 91,185 184,232 $ 162,165
Expenditures for segment’s assets     2,761 1,579  
Nanox. ARC [Member]          
Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss [Line Items]          
Revenues 162 221 329 254  
Cost of revenues 1,948 1,961 3,713 3,570  
Cost of revenues – Impairment of intangible assets      
Segment gross profit (loss) (1,786) (1,740) (3,384) (3,316)  
Research and development, net 3,565 3,759 7,253 7,546  
Sales and marketing 1,445 1,066 3,175 1,885  
General and administrative 4,563 4,322 9,037 8,522  
Other segment items (247) [1] 51 [2] (507) [3] 37 [2]  
Segment operating loss (11,112) (10,938) (22,342) (21,306)  
Depreciation expense 286 270 576 530  
Amortization expense  
Stock based compensation 664 882 1,310 1,817  
Total Assets 67,551 111,972 67,551 111,972  
Expenditures for segment’s assets     2,761 1,569  
Radiology Services [Member]          
Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss [Line Items]          
Revenues 2,950 2,723 6,055 5,328  
Cost of revenues 2,077 2,242 4,785 4,402  
Cost of revenues – Impairment of intangible assets      
Segment gross profit (loss) 873 481 1,270 926  
Research and development, net 28 36 64 65  
Sales and marketing 56 110 265 208  
General and administrative 458 734 919 1,606  
Other segment items [1] [2] [3] [2]  
Segment operating loss 331 (399) 22 (953)  
Depreciation expense 3 2 4 4  
Amortization expense 495 657 990 1,314  
Stock based compensation 157 186 302 370  
Total Assets 19,174 18,774 19,174 18,774  
Expenditures for segment’s assets     10  
AI and Software Solutions [Member]          
Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss [Line Items]          
Revenues 1,044 [4] 96 2,083 [5] 273  
Cost of revenues 3,110 2,077 5,536 4,172  
Cost of revenues – Impairment of intangible assets 40,695   40,695    
Segment gross profit (loss) (42,761) (1,981) (44,148) (3,899)  
Research and development, net 1,114 1,039 2,188 2,201  
Sales and marketing 399 63 624 85  
General and administrative 423 71 728 137  
Other segment items (1) [1] [2] 27 [3] [2]  
Segment operating loss (44,696) (3,154) (47,715) (6,322)  
Depreciation expense 25 27 49 52  
Amortization expense 2,009 1,996 4,019 3,992  
Stock based compensation 48 43 98 90  
Total Assets $ 4,460 $ 53,486 4,460 $ 53,486  
Expenditures for segment’s assets        
[1] Nanox.ARC – loss from disposal of property and equipment, rent income and remeasurement of a settlement with a shareholder.
[2] Nanox.ARC – loss from disposal of property and equipment and rent income.
[3] Nanox.ARC - loss from disposal of property and equipment, rent income and remeasurement of a settlement with a shareholder.
[4] Including $934 thousand related to Nanox Health IT Inc.
[5] Including $1,844 thousand related to Nanox Health IT Inc.